A clear, factual explanation from Dan Marold
FDA Warning Letter to Chill6 Explained: What It Was, What Changed, and What It Means Now
The FDA warning letter related to Chill6™ was a regulatory notice concerning a single ingredient that is only legally permitted to be sold and used in its pure form. It is important to be clear: this was a dietary supplement compliance matter, not a criminal allegation or enforcement action.
This notice prompted a responsible and comprehensive review of the formulation and positioning of Chill6™. Since then, the product has been actively re-evaluated and updated to ensure full regulatory alignment. This article provides clarity on what occurred, what has changed, and how Chill6™ is moving forward with a renewed commitment to compliance, transparency, and product integrity.
Dan Marold & Chill6 Have Been Featured In
If you’ve searched “Chill6” or “Dan Marold” online, you’ve likely seen references to an FDA warning letter issued in July 2021. For many people, that phrase alone creates concern, confusion, or assumptions that aren’t fully accurate.
This post exists to explain, in plain English, what the FDA warning letter to Chill6 actually was, what it required, what changed as a result, and what it means today.
This explanation is based directly on the FDA’s warning letter and the subsequent DOJ complaint for permanent injunction
What Is an FDA Warning Letter?
An FDA warning letter is not a criminal charge, a lawsuit, or a finding of fraud.
It is a regulatory notice used by the FDA to inform a business that, based on a review (often of a website), the agency believes certain aspects of a product or its marketing may not comply with federal law.
Warning letters are intended to:
Notify a company of compliance concerns
Give an opportunity to correct issues
Prevent future regulatory escalation
They are common in the food, supplement, and wellness industries, especially when marketing language crosses regulatory lines.
Why Chill6 Received an FDA Warning Letter
In July 2021, the FDA reviewed the Chill6 website and identified concerns related to how the product was being described and positioned.
According to the FDA and later echoed in the DOJ complaint, the agency took issue with:
Marketing language referencing anxiety, insomnia, PTSD, and similar conditions
The way those references could cause Chill6 to be legally classified as a drug, rather than a beverage or supplement
The inclusion of phenibut, which the FDA does not recognize as an approved dietary ingredient or food additive under U.S. law
The core issue was classification and compliance, not criminal intent or consumer fraud.
What the FDA Was Not Saying
This is where misinformation often begins.
The FDA warning letter did not state that:
Chill6 was a scam
Customers were intentionally harmed
Money was stolen
There was criminal wrongdoing
Dan Marold was charged with a crime
Those claims do not appear in the warning letter.
What the Warning Letter Required
The FDA warning letter essentially required that:
The identified marketing issues be addressed
The product not be sold in violation of FDA regulations
Claims implying diagnosis, treatment, or prevention of disease be removed
Non-compliant ingredients be addressed
In short, it was a directive to correct course and comply.
What Changed After the Warning Letter
The FDA later determined that the steps taken at the time were not sufficient to fully resolve the regulatory concerns. That determination ultimately led to the DOJ seeking a permanent injunction to ensure compliance going forward.
That escalation is important to understand correctly.
The DOJ action was still civil and regulatory, not criminal. Its purpose was to formally stop the distribution of non-compliant products and prevent future violations.
What Has Changed Now
The most important part of this story is what has changed since then.
Chill6 today is not the same product it was in 2021.
Key changes include:
Permanent removal of phenibut from all formulations
A fully redesigned, compliance-focused formula
Elimination of disease, treatment, or medical claims
Professional regulatory and marketing oversight
A compliance-first approach to all future product decisions
These changes directly address the concerns raised in the FDA warning letter and DOJ complaint.
What the FDA Warning Letter Means Today
Today, the FDA warning letter:
Exists as a historical regulatory action
Reflects lessons learned
Does not prohibit compliant future products
Does not represent a criminal record or conviction
Nothing in the warning letter states that Chill6 can never exist again. It simply establishes boundaries that must be respected going forward.
Why Transparency Matters
I believe consumers deserve clarity, not headlines.
The FDA warning letter was a turning point that forced me to learn how regulated this space truly is, especially for founders who start with passion but without institutional support.
I take responsibility for the learning curve. I also believe growth deserves context.
My Final Thoughts
An FDA warning letter is not the end of a story. It is often the beginning of a more disciplined, compliant chapter.
That is exactly what this has become for me and for Chill6.
If you’re here looking for facts instead of fear, you’re in the right place.
The Dan Marold Promise
Today, I stand by what I call The Dan Marold Promise, a personal and professional vow to live differently and to lead with integrity.
Compliance First
Every future product will be 100% lawful, FDA-compliant, and manufactured under GMP-certified standards.
Transparency Always
No more exaggerated claims. Everything will be backed by clear science, honesty, and full disclosure.
Customers Above All Else
People’s trust and safety are more valuable than any
Sustainable Practices
Business will be built responsibly, for the consumer and for the
Redemption in Motion
Mistakes don’t define me, how I rise from them
Redemption in Motion
The tagline of my mission, “Redemption in Motion,” means that redemption is not a one-time event, it’s a daily commitment.
I don’t claim to be perfect. I am simply a man who made mistakes, learned from them, and now lives with the responsibility of turning those lessons into a better path forward.
Moving Forward with Chill6™
The Return of Chill6™ is already in motion. This time, it will be
Reformulated without Phenibut
or any unapproved ingredients
Reviewed by medical professionals
to ensure safety and compliance.
Supported with transparent product information
including full ingredient panels, third-party testing, and certificates of analysis.
Positioned honestly
never making unapproved drug claims, but focusing on wellness and structure-function benefits.
The new Chill6™ will represent not just a product, but a promise, that people can trust what they are putting into their bodies.
Get Ready to Thrive in Business and Life
Sign up to my newsletter